PHARMA fundamentals
An in-depth look to PHARMANIAGA BHD operating, investing, and financing activities
PHARMA free cash flow for Q2 24 is -14.27 M MYR. For 2023, PHARMA free cash flow was -16.38 M MYR and operating cash flow was 46.95 M MYR.
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: MYR
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
TTM